The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on January 23, 2026 for Tau Investment Holdings ....
JBCHEPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Tau Investment Holdings Pte. Ltd., the erstwhile promoter of JB Chemicals & Pharmaceuticals, has reported the release of encumbrance on its entire 7,44,81,519 equity shares (47.55% of total share capital) with effect from 21 January 2026. The encumbrance, which was in the nature of covenants and non-disposal undertakings tied to a 2022 Facilities Agreement with BNP Paribas and other lenders, stood released because these restrictions are no longer applicable. The trigger was the completion of the share sale by Tau Investment to Torrent Pharmaceuticals Limited under a Share Purchase Agreement dated 29 June 2025, pursuant to which Torrent acquired 47.55% stake and took control of the company. Following the transaction, Tau Investment has been reclassified from the 'promoter' category to the 'public' category as it no longer holds any equity shares in the company.
This filing formalises the change of control at JB Chemicals — Torrent Pharmaceuticals is now the new promoter, while the old promoter (Tau Investment / KKR-backed entity) has fully exited. For shareholders, the encumbrance is cleared, removing any lingering pledge risk on the block of shares. The stock may see re-rating or consolidation as the new promoter settles in, but floating supply has also shifted into stronger promoter hands.